NexImmune, Inc. Quarterly Operating Income (Loss) in USD from Q1 2020 to Q2 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
NexImmune, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2020 to Q2 2024.
- NexImmune, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$3.51M, a 54.9% increase year-over-year.
- NexImmune, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$21.6M, a 56.5% increase year-over-year.
- NexImmune, Inc. annual Operating Income (Loss) for 2023 was -$33M, a 47.7% increase from 2022.
- NexImmune, Inc. annual Operating Income (Loss) for 2022 was -$63.1M, a 18.5% decline from 2021.
- NexImmune, Inc. annual Operating Income (Loss) for 2021 was -$53.3M, a 91.2% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)